Stock TSOI THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Therapeutic Solutions International, Inc. Other OTC

Equities

TSOI

US8833781011

Medical Equipment, Supplies & Distribution

Business Summary

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury (TBI), and for daily health. Its flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene, sulforaphane, epigallocatechin gallate, and thymoquinone. Its synergistic blend of ingredients helps the immune system fight off common and complex ailments and promotes healthy T Cell activity. It has developed an allogenic version of StemVacs and has filed patents to cover activating universal donor immune system cells called dendritic cells in a manner so that upon injection they reprogram the body's natural killer (NK) cells. It has obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE), TBI, and lung pathology.

Sales per Business

USD in Million2022Weight2023Weight Delta
Immune Modulation
100.0 %
0 100.0 % 0 100.0 % -52.12%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 0 100.0 % -52.12%

Managers

Managers TitleAgeSince
Timothy Dixon CEO
 Chief Executive Officer 66 11-03-30
James Veltmeyer CTO
 Chief Tech/Sci/R&D Officer 59 18-06-17
Feng Lin CTO
 Chief Tech/Sci/R&D Officer 54 19-09-02
Famela Ramos PRN
 Corporate Officer/Principal 48 -
Serena Robella SAM
 Sales & Marketing - 20-10-11

Members of the board

Members of the board TitleAgeSince
Thomas Ichim BRD
 Director/Board Member 49 16-01-21
Timothy Dixon CEO
 Chief Executive Officer 66 11-03-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,230,116,869 3,423,983,291 ( 80.94 %) 0 80.94 %

Shareholders

NameEquities%Valuation
Timothy Dixon
10.67 %
411,850,245 10.67 % 411 850 $
Thomas Ichim
4.328 %
167,000,000 4.328 % 167 000 $
Jadi Cell LLC
3.405 %
131,402,390 3.405 % 131 402 $
Feng Lin
1.296 %
50,000,000 1.296 % 50 000 $
Famela Ramos
0.1037 %
4,000,000 0.1037 % 4 000 $
Strategic Investment Solutions, Inc. (Illinois)
0.000078 %
3,000 0.000078 % 3 $

Company contact information

Therapeutic Solutions International, Inc.

701 Wild Rose Lane

83525, Elk

+

http://www.therapeuticsolutionsint.com
address Therapeutic Solutions International, Inc.(TSOI)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Medical Devices & Implants

Sector Medical Devices & Implants

1st Jan change Capi.
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.45% 10.63B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+2.17% 8.92B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+19.94% 7.39B
GLAUKOS CORPORATION Stock Glaukos Corporation
+24.43% 4.96B
AXONICS, INC. Stock Axonics, Inc.
+7.46% 3.41B
ENOVIS CORPORATION Stock Enovis Corporation
-1.11% 3.04B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-5.07% 2.23B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-4.22% 2.13B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-20.87% 1.84B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. TSOI Stock
  4. TSOI Stock
  5. Company Therapeutic Solutions International, Inc.